This year has seen huge changes made in the arguments for and against
Open Access. The Wellcome Trust, one of the biggest funders of
biomedical research in the UK, announced it would be enforcing its
mandate for Gold Open Access (where research is freely available from
the publisher; the model used by iMedPub more strictly. The
Finch Report, commissioned by the British government's Science Minister
recommended a move to Gold Open Access (OA), although there were some
concerns over how this will be funded. Finally, the UK Research
Councils introduced stricter conditions on making research available
either through author-pays OA or by depositing in online repositories
(known as Green OA).
This is all very UK-centric, but the same
trends are emerging throughout the world, with petitions plaguing the
White House and European funders mandating some form of Open Access by
2016. The UK's Department for International Development has announced
it will fund OA for the research it funds internationally, with the
International Development Secretary, Andrew Mitchell, pointing out,
2the most groundbreaking research is of no use to anyone if it sits on a
shelf gathering dust".
iMedPub's policy is to ensure that all
publications in all journals comply with these Open Access mandates,
through deposition in PubMed Central, free online access without
restriction, and the freedom for anyone to use and reuse the published
data, subject to correct attribution, thanks to Creative Commons
licensing. Your Journal Development Editor can provide more information
on how this applies to your journal and authors.
0 comentarios:
Post a Comment